Congratulations!

[Valid Atom 1.0] This is a valid Atom 1.0 feed.

Recommendations

This feed is valid, but interoperability with the widest range of feed readers could be improved by implementing the following recommendations.

Source: http://www.pillole.org/public/aspnuke/feedatom10.asp

  1. <?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom" xml:lang="it"><title type="text">pillole.org</title><subtitle type="text">Pillole di medicina telematica info professionali mediche</subtitle><id>http://www.pillole.org/public/aspnuke/news.asp</id><link rel="alternate" type="application/xhtml+xml" href="http://www.pillole.org/"/><link rel="self" type="application/atom+xml" href="http://www.pillole.org/public/aspnuke/feedatom10.asp"/><author><name>Pillole.org</name><uri>http://www.pillole.org</uri><email>info@pillole.org</email></author><rights>Copyright (c) 2005, Pillole.org</rights><updated>2025-10-31T00:00:00+01:00</updated><entry><title type="html">Le radici sociali della malattia - Parte quarta</title><category term="news" scheme="http://www.pillole.org/public/aspnuke/news.asp/" label="News" /><id>http://www.pillole.org/public/aspnuke/news.asp,2025-10-31:?id=8835</id><link href="http://www.pillole.org/public/aspnuke/news.asp?id=8835" /><link rel="alternate" href="http://www.pillole.org/public/aspnuke/news.asp?id=8835" type="application/xhtml+xml" hreflang="it" /><updated>2025-10-30T06:28:00+01:00</updated></entry><entry><title type="html">I timori degli effetti collaterali allontanano gli adolescenti dai vaccini</title><summary type="html">Sulle soglie dell&#8217; autunno ci trova alle soglie di quella che sembrava un&#8217; abitudine consolidata: quella della vaccinazione. Ma si amplifica il timore che si consolidi una riluttanza aprioristica, spinta essenzialmente dai social media.</summary><category term="news" scheme="http://www.pillole.org/public/aspnuke/news.asp/" label="News" /><id>http://www.pillole.org/public/aspnuke/news.asp,2025-10-31:?id=8857</id><link href="http://www.pillole.org/public/aspnuke/news.asp?id=8857" /><link rel="alternate" href="http://www.pillole.org/public/aspnuke/news.asp?id=8857" type="application/xhtml+xml" hreflang="it" /><updated>2025-10-29T00:39:00+01:00</updated></entry><entry><title type="html">SOS: l&#8217;intelligenza artificiale erode le capacit&#224; cognitive dei medici</title><summary type="html">Il rischio di deskilling, ovvero la perdita progressiva di competenze professionali a causa della delega sistematica a tecnologie automatizzate</summary><category term="news" scheme="http://www.pillole.org/public/aspnuke/news.asp/" label="News" /><id>http://www.pillole.org/public/aspnuke/news.asp,2025-10-31:?id=8843</id><link href="http://www.pillole.org/public/aspnuke/news.asp?id=8843" /><link rel="alternate" href="http://www.pillole.org/public/aspnuke/news.asp?id=8843" type="application/xhtml+xml" hreflang="it" /><updated>2025-10-26T07:25:00+01:00</updated></entry><entry><title type="html">Diabete di tipo 2: una linea guida &quot;vivente&quot;</title><summary type="html">Una living systematic review ha paragonato tra loro i vari trattamenti per il diabete di tipo 2 e personalizzato la terapia sulla base del profilo cardiovascolare e renale del paziente.
  2. </summary><category term="news" scheme="http://www.pillole.org/public/aspnuke/news.asp/" label="News" /><id>http://www.pillole.org/public/aspnuke/news.asp,2025-10-31:?id=8825</id><link href="http://www.pillole.org/public/aspnuke/news.asp?id=8825" /><link rel="alternate" href="http://www.pillole.org/public/aspnuke/news.asp?id=8825" type="application/xhtml+xml" hreflang="it" /><updated>2025-10-26T06:28:00+01:00</updated></entry><entry><title type="html">Novit&#224; in Gazzetta Ufficiale 18 - 24 ottobre 2025</title><summary type="html">Provvedimenti di interesse medico-sanitario pubblicati in Gazzetta Ufficiale: 18 - 24 ottobre 2025.</summary><category term="news" scheme="http://www.pillole.org/public/aspnuke/news.asp/" label="News" /><id>http://www.pillole.org/public/aspnuke/news.asp,2025-10-31:?id=8858</id><link href="http://www.pillole.org/public/aspnuke/news.asp?id=8858" /><link rel="alternate" href="http://www.pillole.org/public/aspnuke/news.asp?id=8858" type="application/xhtml+xml" hreflang="it" /><updated>2025-10-25T01:00:00+01:00</updated></entry><entry><title type="html">Le radici sociali della malattia - Parte terza</title><category term="news" scheme="http://www.pillole.org/public/aspnuke/news.asp/" label="News" /><id>http://www.pillole.org/public/aspnuke/news.asp,2025-10-31:?id=8834</id><link href="http://www.pillole.org/public/aspnuke/news.asp?id=8834" /><link rel="alternate" href="http://www.pillole.org/public/aspnuke/news.asp?id=8834" type="application/xhtml+xml" hreflang="it" /><updated>2025-10-23T06:28:00+01:00</updated></entry><entry><title type="html">Adrenalina spray nasale per le gravi reazioni allergiche?</title><summary type="html">E&#8217; stato gia&#8217; approvato da tempo da FDA e da EMA lo spray nasale che dovrebbe affiancare o sostituire l&#8217; iniezione intramuscolare di adrenalina per i pazienti soggetti a gravi crisi anafilatttiche respiratorie; mancava pero&#8217; finora l&#8217; approvazione  dell&#8217; Aifa per la commercializzazione in Italia. La conclusione dell&#8217; iter burocratico e&#8217; previsto per il 2026, sperabilmente abbastanza presto.</summary><category term="news" scheme="http://www.pillole.org/public/aspnuke/news.asp/" label="News" /><id>http://www.pillole.org/public/aspnuke/news.asp,2025-10-31:?id=8854</id><link href="http://www.pillole.org/public/aspnuke/news.asp?id=8854" /><link rel="alternate" href="http://www.pillole.org/public/aspnuke/news.asp?id=8854" type="application/xhtml+xml" hreflang="it" /><updated>2025-10-23T00:17:00+01:00</updated></entry><entry><title type="html">Scarsa l&#8217; aderenza alle terapie antiobesita&#8217;</title><summary type="html">Si e&#8217; diffuso ampiamente il trattamento con farmaci GLP-1 (semaglutide) inizialmente studiati per il diabete, poi utilizzati con entusiasmo per l&#8217; obesita&#8217;. Un ampio studio danese ha voluto verificare l&#8217; aderenza ed i risultati di questo trattamento: [b]spesso vengono interrotti entro un anno.[/b]</summary><category term="news" scheme="http://www.pillole.org/public/aspnuke/news.asp/" label="News" /><id>http://www.pillole.org/public/aspnuke/news.asp,2025-10-31:?id=8841</id><link href="http://www.pillole.org/public/aspnuke/news.asp?id=8841" /><link rel="alternate" href="http://www.pillole.org/public/aspnuke/news.asp?id=8841" type="application/xhtml+xml" hreflang="it" /><updated>2025-10-21T00:58:00+01:00</updated></entry><entry><title type="html">La fiducia nei confronti della Intelligenza Artificiale &#232; meritata?</title><summary type="html">L&#8217;intelligenza artificiale (IA) &#232; ormai una presenza quotidiana. Ci&#242; pone una questione cruciale: possiamo fidarci di una macchina come ci fidiamo di una persona? E, soprattutto, che tipo di fiducia dovremmo accordarle?</summary><category term="news" scheme="http://www.pillole.org/public/aspnuke/news.asp/" label="News" /><id>http://www.pillole.org/public/aspnuke/news.asp,2025-10-31:?id=8831</id><link href="http://www.pillole.org/public/aspnuke/news.asp?id=8831" /><link rel="alternate" href="http://www.pillole.org/public/aspnuke/news.asp?id=8831" type="application/xhtml+xml" hreflang="it" /><updated>2025-10-19T07:19:00+01:00</updated></entry><entry><title type="html">Linee guida 2025 sull'ipertensione</title><summary type="html">Sono state pubblicate da parte dell'AHA e dell'ACC le nuove linee guida sull'ipertensione che aggiornano quelle precedenti del 2017.
  3. </summary><category term="news" scheme="http://www.pillole.org/public/aspnuke/news.asp/" label="News" /><id>http://www.pillole.org/public/aspnuke/news.asp,2025-10-31:?id=8806</id><link href="http://www.pillole.org/public/aspnuke/news.asp?id=8806" /><link rel="alternate" href="http://www.pillole.org/public/aspnuke/news.asp?id=8806" type="application/xhtml+xml" hreflang="it" /><updated>2025-10-19T06:28:00+01:00</updated></entry></feed>

If you would like to create a banner that links to this page (i.e. this validation result), do the following:

  1. Download the "valid Atom 1.0" banner.

  2. Upload the image to your own server. (This step is important. Please do not link directly to the image on this server.)

  3. Add this HTML to your page (change the image src attribute if necessary):

If you would like to create a text link instead, here is the URL you can use:

http://www.feedvalidator.org/check.cgi?url=http%3A//www.pillole.org/public/aspnuke/feedatom10.asp

Copyright © 2002-9 Sam Ruby, Mark Pilgrim, Joseph Walton, and Phil Ringnalda